Clinical Trial Update: A Study to Assess Radiation Induced Mucositis in Patients of Head and Neck Cancer Administered Chemo-Radiation With or Without P276-00 [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating P276-00 to prevent radiation-induced mucositis in head and neck cancer patients undergoing chemo-radiation; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• P276-00 (P276-00)

Snippet

Sponsor: Piramal Enterprises Limited | Conditions: Radiation Induced Mucositis in Head and Neck Cancer | Phase 2 | Status: COMPLETED